PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 23107872-9 2013 Ca(2+) ionophore ionomycin (1 muM) and oxidative stress (30-minute exposure to 0.3 mM of tert-butylhydroperoxide) increased annexin-V-binding, effects again blunted by 30 muM of probucol. tert-Butylhydroperoxide 89-112 latexin Homo sapiens 30-33 26052623-6 2016 The protective effects of isolated compounds (10 and 20 muM) against oxidative stress induced by tert-butyl hydroperoxide (t-BHP) in HepG2 cells were investigated through the measurement of aspartate aminotransferase (AST), alanine transaminase (ALT), and superoxide dismutase (SOD) levels. tert-Butylhydroperoxide 97-121 latexin Homo sapiens 56-59 26052623-6 2016 The protective effects of isolated compounds (10 and 20 muM) against oxidative stress induced by tert-butyl hydroperoxide (t-BHP) in HepG2 cells were investigated through the measurement of aspartate aminotransferase (AST), alanine transaminase (ALT), and superoxide dismutase (SOD) levels. tert-Butylhydroperoxide 123-128 latexin Homo sapiens 56-59 26052623-8 2016 Oxidant-induced damage by 200 muM t-BHP in HepG2 cells was inhibited by compounds 1, 4, and 5 (10 and 20 muM), or quercetin (10 muM; positive control). tert-Butylhydroperoxide 34-39 latexin Homo sapiens 30-33 26052623-8 2016 Oxidant-induced damage by 200 muM t-BHP in HepG2 cells was inhibited by compounds 1, 4, and 5 (10 and 20 muM), or quercetin (10 muM; positive control). tert-Butylhydroperoxide 34-39 latexin Homo sapiens 105-108 26052623-8 2016 Oxidant-induced damage by 200 muM t-BHP in HepG2 cells was inhibited by compounds 1, 4, and 5 (10 and 20 muM), or quercetin (10 muM; positive control). tert-Butylhydroperoxide 34-39 latexin Homo sapiens 105-108 24582277-6 2014 Among the tested compounds, 6"-O-caffeoylacteoside exhibited the most potent cytoprotective activity with an IC50 value of 0.8+-0.1 muM against t-BHP-induced toxicity. tert-Butylhydroperoxide 144-149 latexin Homo sapiens 132-135 29630935-7 2018 The most sensitive and reliable combination for this ROS assay was 10 muM DCFDA with 25 muM TBHP; since higher concentrations of DCFDA compromised cell viability. tert-Butylhydroperoxide 92-96 latexin Homo sapiens 70-73 29630935-7 2018 The most sensitive and reliable combination for this ROS assay was 10 muM DCFDA with 25 muM TBHP; since higher concentrations of DCFDA compromised cell viability. tert-Butylhydroperoxide 92-96 latexin Homo sapiens 88-91 24486304-4 2014 KEY FINDINGS: When tBHP was used to induce lipid peroxidation, lycopene was the most efficient carotenoid (IC50=2.2 +- 0.4 muM), while lutein was the most efficient (IC50=2.5 +- 0.7 muM) when peroxyl radicals (ROO) were generated by AAPH. tert-Butylhydroperoxide 19-23 latexin Homo sapiens 123-126 24486304-4 2014 KEY FINDINGS: When tBHP was used to induce lipid peroxidation, lycopene was the most efficient carotenoid (IC50=2.2 +- 0.4 muM), while lutein was the most efficient (IC50=2.5 +- 0.7 muM) when peroxyl radicals (ROO) were generated by AAPH. tert-Butylhydroperoxide 19-23 latexin Homo sapiens 182-185 22610911-3 2013 Caco-2 cells pretreated with ferulate (5 or 15 muM) were exposed to t-BHP (100 muM), and ferulate suppressed the t-BHP-mediated increases in reactive species and epithelial permeability in Caco-2 cells. tert-Butylhydroperoxide 68-73 latexin Homo sapiens 79-82 22610911-3 2013 Caco-2 cells pretreated with ferulate (5 or 15 muM) were exposed to t-BHP (100 muM), and ferulate suppressed the t-BHP-mediated increases in reactive species and epithelial permeability in Caco-2 cells. tert-Butylhydroperoxide 113-118 latexin Homo sapiens 47-50 22610911-3 2013 Caco-2 cells pretreated with ferulate (5 or 15 muM) were exposed to t-BHP (100 muM), and ferulate suppressed the t-BHP-mediated increases in reactive species and epithelial permeability in Caco-2 cells. tert-Butylhydroperoxide 113-118 latexin Homo sapiens 79-82 23107872-9 2013 Ca(2+) ionophore ionomycin (1 muM) and oxidative stress (30-minute exposure to 0.3 mM of tert-butylhydroperoxide) increased annexin-V-binding, effects again blunted by 30 muM of probucol. tert-Butylhydroperoxide 89-112 latexin Homo sapiens 171-174 22956110-5 2012 Oxidative stress was induced by exposure of the cells to tert-butyl hydroperoxide (TBH) for 1 h. TBH (3,000 muM) induced an increase in biomarkers of oxidative stress, while maintaining cell viability and proliferation. tert-Butylhydroperoxide 57-81 latexin Homo sapiens 108-111 22956110-5 2012 Oxidative stress was induced by exposure of the cells to tert-butyl hydroperoxide (TBH) for 1 h. TBH (3,000 muM) induced an increase in biomarkers of oxidative stress, while maintaining cell viability and proliferation. tert-Butylhydroperoxide 83-86 latexin Homo sapiens 108-111 22956110-5 2012 Oxidative stress was induced by exposure of the cells to tert-butyl hydroperoxide (TBH) for 1 h. TBH (3,000 muM) induced an increase in biomarkers of oxidative stress, while maintaining cell viability and proliferation. tert-Butylhydroperoxide 97-100 latexin Homo sapiens 108-111 22956110-6 2012 In relation to the apical uptake of (3)H-FA, TBH (3,000 muM) reduced the cellular accumulation of (3)H-FA (10 nM), although the characteristics (kinetics, pH dependence, and inhibitory profile) of (3)H-FA uptake were not changed. tert-Butylhydroperoxide 45-48 latexin Homo sapiens 56-59 20510595-6 2011 Under 400 muM t-BHP treatment, QZG cell displayed significant loss of viability and dramatic morphological changes characterized by changing in shape from triangle to spherical, disappearance of cell cilia, swollen mitochondrial and typical apoptotic alteration such as condensation of chromatin, and appearance of crescent under light microscopy and electronic microscopy, respectively. tert-Butylhydroperoxide 14-19 latexin Homo sapiens 10-13 20510595-9 2011 25 muM rosiglitazone treatment inhibited the t-BHP-induced cell toxicity significantly by restoring the cell viability, reducing cell population undergone apoptosis to normal level (3.5%) and ameliorating t-BHP-induced pathological changes. tert-Butylhydroperoxide 45-50 latexin Homo sapiens 3-6 20510595-9 2011 25 muM rosiglitazone treatment inhibited the t-BHP-induced cell toxicity significantly by restoring the cell viability, reducing cell population undergone apoptosis to normal level (3.5%) and ameliorating t-BHP-induced pathological changes. tert-Butylhydroperoxide 205-210 latexin Homo sapiens 3-6 20510595-10 2011 Real-time RT-PCR results showed that 400 muM t-BHP caused dramatic down-regulation of PPARgamma expression in QZG cells, whereas combining treatment with 25 muM rosiglitazone resistant to PPARgamma expression to normal level partially. tert-Butylhydroperoxide 45-50 latexin Homo sapiens 41-44 21707031-8 2011 Oxidative stress (30 min 0.3 mM tert-butylhydroperoxide) again significantly increased Fluo-3 fluorescence and triggered annexin binding, effects again in part significantly blunted by phlorhizin (Fluo-3 fluorescence >= 50 muM, annexin-binding >= 10 muM). tert-Butylhydroperoxide 32-55 latexin Homo sapiens 226-229 21707031-8 2011 Oxidative stress (30 min 0.3 mM tert-butylhydroperoxide) again significantly increased Fluo-3 fluorescence and triggered annexin binding, effects again in part significantly blunted by phlorhizin (Fluo-3 fluorescence >= 50 muM, annexin-binding >= 10 muM). tert-Butylhydroperoxide 32-55 latexin Homo sapiens 256-259